Seeking Alpha

Medgenics (MDGN +3.2%) expands the range of patent coverage for its therapeutic proteins and...

Medgenics (MDGN +3.2%) expands the range of patent coverage for its therapeutic proteins and thereby broadens the scope of its intellectual property as the company receives a notice of allowance from the U.S. Patent Office. MDGN now has 45 patents granted.
Comments (1)
  • Sammyboy12
    , contributor
    Comments (50) | Send Message
     
    Could this be the long-awaited recovery of the SP to the deserved heights?
    22 Apr 2013, 12:40 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|